Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2022

Segment Reporting

Schedule of reportable operating segment information

	CareVention HealthCare		Shared Services and Other		Consolidated
Revenue:
Three Months Ended June 30, 2022
Product revenue	$	55,892	$	—	$	55,892
Service revenue
PACE solutions		15,853		—		15,853
Medication safety services		—		774		774
Software subscription and services		—		78		78
Total service revenue		15,853		852		16,705
Total revenue	$	71,745	$	852	$	72,597
Three Months Ended June 30, 2021
Product revenue	$	46,858	$	—	$	46,858
Service revenue
PACE solutions		14,347		—		14,347
Medication safety services		—		3,037		3,037
Software subscription and services		—		55		55
Total service revenue		14,347		3,092		17,439
Total revenue	$	61,205	$	3,092	$	64,297
Six Months Ended June 30, 2022
Product revenue	$	106,865	$	—	$	106,865
Service revenue
PACE solutions		31,188		—		31,188
Medication safety services		—		1,493		1,493
Software subscription and services		—		161		161
Total service revenue		31,188		1,654		32,842
Total revenue	$	138,053	$	1,654	$	139,707
Six Months Ended June 30, 2021
Product revenue	$	88,700	$	—	$	88,700
Service revenue
PACE solutions		28,266		—		28,266
Medication safety services		—		5,997		5,997
Software subscription and services		—		112		112
Total service revenue		28,266		6,109		34,375
Total revenue	$	116,966	$	6,109	$	123,075

	CareVention HealthCare		Shared Services and Other		Consolidated
Adjusted EBITDA (loss) from Continuing Operations:
Three Months Ended June 30, 2022
Adjusted EBITDA (loss)	$	13,396	$	(11,339)	$	2,057
Three Months Ended June 30, 2021
Adjusted EBITDA (loss)	$	14,059	$	(10,796)	$	3,263
Six Months Ended June 30, 2022
Adjusted EBITDA (loss)	$	25,480	$	(22,341)	$	3,139
Six Months Ended June 30, 2021
Adjusted EBITDA (loss)	$	26,969	$	(22,123)	$	4,846

Schedules of reconciliation of net loss to Adjusted EBITDA

	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
Reconciliation of Net Loss to Adjusted EBITDA from Continuing Operations
Net loss	$	(49,610)	$	(21,081)	$	(77,803)	$	(40,573)
Add:
Interest expense, net		2,444		2,182		4,713		4,729
Income tax expense		159		81		375		202
Depreciation and amortization		5,489		4,980		11,231		9,781
Impairment charges		—		—		4,062		—
Business optimization expenses		—		—		787		—
Severance costs		—		162		575		162
Executive transition		150		—		150		—
Divestiture-related expense		1,414		—		1,534		—
Acquisition-related expense		—		99		—		217
Stock-based compensation expense		5,092		9,827		12,795		17,199
Loss from discontinued operations		36,919		7,013		44,720		13,129
Adjusted EBITDA from continuing operations	$	2,057	$	3,263	$	3,139	$	4,846
Adjusted EBITDA from discontinued operations		1,117		2,700		2,557		4,716
Total Adjusted EBITDA	$	3,174	$	5,963	$	5,696	$	9,562

	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
Reconciliation of Net Loss from Discontinued Operations, net of tax to Adjusted EBITDA from Discontinued Operations
Net loss from discontinued operations, net of tax	$	(36,919)	$	(7,013)	$	(44,720)	$	(13,129)
Add:
Income tax (benefit) expense		(686)		52		(568)		130
Depreciation and amortization		—		6,639		7,331		13,463
Impairment charges		35,608		—		36,448		—
Settlement		1,448		500		1,448		500
Divestiture-related expense		66		—		112		—
Stock-based compensation expense		1,600		2,522		2,506		3,752
Adjusted EBITDA from discontinued operations	$	1,117	$	2,700	$	2,557	$	4,716